These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17441371)

  • 1. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
    Tekieli Ł; Pieniazek P; Podolec P; Tomkiewicz-Pajak L; Płazak W; Musiałek P; Leśniak-Sobelga A; Przewłocki T; Biernacka B; Zmudka K; Tracz W
    Przegl Lek; 2006; 63(8):628-32. PubMed ID: 17441371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
    Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term exercise capacity in patients with hypertrophic cardiomyopathy treated with percutaneous transluminal septal myocardial ablation.
    Malek LA; Chojnowska L; Klopotowski M; Maczynska R; Demkow M; Witkowski A; Kusmierczyk B; Piotrowicz E; Konka M; Dabrowski M; Ruzyllo W
    Eur J Heart Fail; 2008 Nov; 10(11):1123-6. PubMed ID: 18840395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J; Honek T
    Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
    Seggewiss H; Faber L; Gleichmann U
    Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
    Krejcí J; Groch L; Meluzín J; Vykypel T; Halámek J; Vitovec J
    Vnitr Lek; 2006 Apr; 52(4):313-20. PubMed ID: 16755987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
    Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
    J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
    Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
    Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy].
    Qiao SB; Gao RL; You SJ; Yuan JS; Chen JL; Yang YJ
    Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):210-2. PubMed ID: 16624154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
    Li ZQ; Cheng TO; Zhang WW; Qiao SB; Zhao LY; Jin YZ; Guan RM; Liu L
    Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
    Zeng Z; Wang F; Dou X; Zhang S; Pu J
    Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
    Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
    Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.
    Faber L; Meissner A; Ziemssen P; Seggewiss H
    Heart; 2000 Mar; 83(3):326-31. PubMed ID: 10677415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-surgical myocardial reduction in hypertrophic obstructive cardiomyopathy.
    Mutlak D; Gruberg L; Reisner S; Markiewicz W
    Isr Med Assoc J; 2002 Feb; 4(2):86-90. PubMed ID: 11875998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience.
    Faber L; Seggewiss H; Welge D; Fassbender D; Schmidt HK; Gleichmann U; Horstkotte D
    Eur J Echocardiogr; 2004 Oct; 5(5):347-55. PubMed ID: 15341870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Akita K; Maekawa Y; Kohno T; Tsuruta H; Murata M; Fukuda K
    Heart Vessels; 2017 Nov; 32(11):1320-1326. PubMed ID: 28555387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
    Kurita T; Tsuchikane E; Tanaka N; Suzuki T
    Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography.
    Faber L; Seggewiss H; Gleichmann U
    Circulation; 1998 Dec; 98(22):2415-21. PubMed ID: 9832486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular endocardial pacing predicts the reduction of left ventricular outflow tract pressure gradient immediately after percutaneous transseptal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
    Chen SL; Dai ZL; Li ZQ; Hu ZY; Ye F; Zhang JJ; Zhang FF; Luo J; Zhu ZS; Lin S; Wu CQ; Tian NL
    Chin Med J (Engl); 2007 Apr; 120(7):562-8. PubMed ID: 17442203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.